# Efficacy and Safety of SP-8203 in Patients With Ischemic Stroke Requiring rtPA

> **NCT04479449** · PHASE2 · COMPLETED · sponsor: **Shin Poong Pharmaceutical Co. Ltd.** · enrollment: 178 (actual)

## Conditions studied

- Ischemic Stroke

## Interventions

- **DRUG:** SP-8203
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04479449
- **Lead sponsor:** Shin Poong Pharmaceutical Co. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-18
- **Primary completion:** 2020-10-19
- **Final completion:** 2020-12-18
- **Target enrollment:** 178 (ACTUAL)
- **Last updated:** 2023-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04479449

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04479449, "Efficacy and Safety of SP-8203 in Patients With Ischemic Stroke Requiring rtPA". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04479449. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*